论文部分内容阅读
目的分析我院住院部患者口服降糖药物的应用情况,为临床合理用药提供参考依据。方法按WHO推荐的限定日剂量(DDD值)计算,用频率排序法分析。结果葡萄糖苷酶抑制剂使用频率较高,占31.13%,其次是双胍类,占21.49%。结论葡萄糖苷酶抑制剂是新型口服降糖药物,用于降低餐后血糖,其降糖效果显著、安全,是目前糖尿病患者的首选药物。
Objective To analyze the application of oral hypoglycemic agents in inpatients in our hospital to provide a reference for clinical rational drug use. Methods According to the WHO recommended limit daily dose (DDD value) calculations, using frequency sorting analysis. Results Glucosidase inhibitors were used frequently, accounting for 31.13%, followed by biguanides, accounting for 21.49%. Conclusion Glucosidase inhibitor is a new oral hypoglycemic drug used to reduce postprandial blood glucose, its hypoglycemic effect is significant and safe, is currently the drug of choice for patients with diabetes.